Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Galapagos NV

GLPGFPNK
Healthcare
Biotechnology
$33.27
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Galapagos NV (GLPGF) Stock Overview

Explore Galapagos NV’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio5.92
EPS (TTM)$-8.02
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$34.21
3 Months$36.75
1 Year Target$31.09

GLPGF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Galapagos NV (GLPGF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $31.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.92 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
43.24%
5-Day Change
N/A
1-Month Change
-2.15%
3-Month Change
6.33%
6-Month Change
-0.54%
Year-to-Date (YTD) Change
6.33%
1-Year Change
44.59%
3-Year Change
-14.69%
5-Year Change
-58.80%
All-Time (Max) Change
219.90%

Contact Information

32 1 534 29 00
Generaal De Wittelaan L11 A3, Mechelen, NaN, 2800

Company Facts

7,040 Employees
IPO DateAug 3, 2009
CountryBE
Actively Trading

Frequently Asked Questions